GH - Guardant Health - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GH is currently covered by 17 analysts with an average price target of $67.35. This is a potential upside of $20.5 (43.76%) from yesterday's end of day stock price of $46.85.

Guardant Health's activity chart (see below) currently has 112 price targets and 125 ratings on display. The stock rating distribution of GH is 5.56% HOLD and 94.44% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.68% with an average time for these price targets to be met of 166.76 days.

Highest price target for GH is $60, Lowest price target is $40, average price target is $50.38.

Most recent stock forecast was given by MASON CARRICO from STEPHENS on 26-Mar-2025. First documented stock forecast 29-Oct-2018.

Currently out of the existing stock ratings of GH, 3 are a HOLD (5.56%), 51 are a BUY (94.44%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$55

$6.7 (13.87%)

$44

1 months 7 days ago
(26-Mar-2025)

1/4 (25%)

$9.16 (19.98%)

242

Buy

$50

$1.7 (3.52%)

$34

2 months 7 days ago
(26-Feb-2025)

7/10 (70%)

$9.65 (23.92%)

220

Buy

$59

$10.7 (22.15%)

$39

2 months 9 days ago
(24-Feb-2025)

2/3 (66.67%)

$11.6 (24.47%)

24

Buy

$52

$3.7 (7.66%)

$47

2 months 9 days ago
(24-Feb-2025)

3/4 (75%)

$4.6 (9.70%)

439

Buy

$56

$7.7 (15.94%)

$49

2 months 9 days ago
(24-Feb-2025)

7/12 (58.33%)

$8.6 (18.14%)

224

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GH (Guardant Health) average time for price targets to be met?

On average it took 166.76 days on average for the stock forecasts to be realized with a an average price target met ratio 49.68

Which analyst has the current highest performing score on GH (Guardant Health) with a proven track record?

PUNEET SOUDA

Which analyst has the most public recommendations on GH (Guardant Health)?

Puneet Souda has 11 price targets and 6 ratings on GH

Which analyst is the currently most bullish on GH (Guardant Health)?

Patrick Donnelly with highest potential upside - $48.48

Which analyst is the currently most reserved on GH (Guardant Health)?

Max Masucci with lowest potential downside - -$11.3

Guardant Health in the News

Guardant Health First Quarter 2025 Earnings: Beats Expectations

Guardant Health (NASDAQ:GH) First Quarter 2025 Results Key Financial Results Revenue: US$203.5m (up 21% from 1Q 2024). Net loss: US$95.2m (loss narrowed by 17% from 1Q 2024). US$0.77 loss per share (improved from US$0.94 loss in 1Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.NasdaqGS:GH...

Q1 2025 Guardant Health Inc Earnings Call

Participants Zarak Khurshid; Investor Relations; Guardant Health Inc Helmy Eltoukhy; Chairman of the Board, Co-Chief Executive Officer; Guardant Health Inc Amirali Talasaz; Co-Chief Executive Officer, Director; Guardant Health Inc Michael Bell; Chief Financial Officer; Guardant Health Inc Mark Massaro; Analyst; BTIG Tycho Peterson; Analyst; Jefferies William Bonello; Analyst; Craig-Hallum Subhalaxmi Nambi; Analyst; Guggenheim Partners Puneet...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?